245 related articles for article (PubMed ID: 18257600)
1. Use of beta-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues.
Andrus MR; Loyed JV
Drugs Aging; 2008; 25(2):131-44. PubMed ID: 18257600
[TBL] [Abstract][Full Text] [Related]
2. [The place of β-adrenoblockers in the treatment of cardiovascular disease in patients with chronic obstructive pulmonary disease].
Statsenko ME; Derevianchenko MV
Kardiologiia; 2012; 52(12):57-63. PubMed ID: 23237442
[TBL] [Abstract][Full Text] [Related]
3. Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents.
Coats AJ
Drugs Aging; 2006; 23(2):93-9. PubMed ID: 16536633
[TBL] [Abstract][Full Text] [Related]
4. β-Adrenoceptor modulation in chronic obstructive pulmonary disease: present and future perspectives.
Matera MG; Calzetta L; Cazzola M
Drugs; 2013 Oct; 73(15):1653-63. PubMed ID: 24127222
[TBL] [Abstract][Full Text] [Related]
5. Beta Adrenergic Blocker Use in Patients With Chronic Obstructive Pulmonary Disease and Concurrent Chronic Heart Failure With a Low Ejection Fraction.
Mtisi TF; Frishman WH
Cardiol Rev; 2020; 28(1):20-25. PubMed ID: 31804289
[TBL] [Abstract][Full Text] [Related]
6. [Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD].
Glaab T; Weiss T
Internist (Berl); 2004 Feb; 45(2):221-7. PubMed ID: 14991165
[TBL] [Abstract][Full Text] [Related]
7. β-Blockers and chronic obstructive pulmonary disease: inappropriate avoidance?
Minor DS; Meyer AM; Long RC; Butler KR
J Clin Hypertens (Greenwich); 2013 Dec; 15(12):925-30. PubMed ID: 24102872
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
Sirak TE; Jelic S; Le Jemtel TH
J Am Coll Cardiol; 2004 Aug; 44(3):497-502. PubMed ID: 15358010
[TBL] [Abstract][Full Text] [Related]
9. beta-Adrenoceptor antagonists in elderly patients with heart failure: a critical review of their efficacy and tolerability.
Dobre D; Haaijer-Ruskamp FM; Voors AA; van Veldhuisen DJ
Drugs Aging; 2007; 24(12):1031-44. PubMed ID: 18020535
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure.
Matera MG; Martuscelli E; Cazzola M
Pulm Pharmacol Ther; 2010 Feb; 23(1):1-8. PubMed ID: 19833222
[TBL] [Abstract][Full Text] [Related]
11. Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions.
Albouaini K; Andron M; Alahmar A; Egred M
Int J Chron Obstruct Pulmon Dis; 2007; 2(4):535-40. PubMed ID: 18268926
[TBL] [Abstract][Full Text] [Related]
12. Is the use of beta-blockers in COPD still an unresolved dilemma?
Foresi A; Cavigioli G; Signorelli G; Pozzoni MB; Olivieri D
Respiration; 2010; 80(3):177-87. PubMed ID: 20639691
[TBL] [Abstract][Full Text] [Related]
13. Overcoming gaps in the management of asthma in older patients: new insights.
Barua P; O'Mahony MS
Drugs Aging; 2005; 22(12):1029-59. PubMed ID: 16363886
[TBL] [Abstract][Full Text] [Related]
14. Use of beta-blockers in patients with COPD.
Andrus MR; Holloway KP; Clark DB
Ann Pharmacother; 2004 Jan; 38(1):142-5. PubMed ID: 14742808
[TBL] [Abstract][Full Text] [Related]
15. Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease.
Lipworth B; Skinner D; Devereux G; Thomas V; Ling Zhi Jie J; Martin J; Carter V; Price DB
Heart; 2016 Dec; 102(23):1909-1914. PubMed ID: 27380949
[TBL] [Abstract][Full Text] [Related]
16. [Controversies and dilemmas on the use of beta-blockers in treatment of associated cardiovascular disease in patients with chronic obstructive pulmonary disease].
Pescaru C; Tudorache V; Oancea C
Pneumologia; 2010; 59(1):27-30. PubMed ID: 20432790
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review.
Salpeter SR
Drugs Aging; 2004; 21(6):405-14. PubMed ID: 15084142
[TBL] [Abstract][Full Text] [Related]
18. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.
Canepa M; Franssen FME; Olschewski H; Lainscak M; Böhm M; Tavazzi L; Rosenkranz S
JACC Heart Fail; 2019 Oct; 7(10):823-833. PubMed ID: 31521680
[TBL] [Abstract][Full Text] [Related]
20. Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.
Ellison KE; Gandhi G
Drugs; 2005; 65(6):787-97. PubMed ID: 15819591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
